Home Stock

Stock Research: Orion

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Orion

HEX:ORNBV FI0009014377
61
  • Value
    37
  • Growth
    66
  • Safety
    Safety
    88
  • Combined
    74
  • Sentiment
    36
  • 360° View
    360° View
    61
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Orion Oyj is a pharmaceutical company that researches, develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company operates within the pharmaceutical industry, focusing on central nervous system disorders, oncology, and respiratory diseases. Orion Oyj is based in Finland. In the last fiscal year, the company had a market cap of $10,792 million, profits of $980 million, and revenue of $1,597 million with 3880 employees.

more

ANALYSIS: With an Obermatt 360° View of 61 (better than 61% compared with alternatives), overall professional sentiment and financial characteristics for the stock Orion are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Orion. The consolidated Growth Rank has a good rank of 66, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 66% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 88 which means that the company has a financing structure that is safer than 88% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 37 which means that the share price of Orion is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 63% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 36, which means that professional investors are more pessimistic about the stock than for 64% of alternative investment opportunities. ...read more

more
Strongest Rank Market Pulse
Weakest Rank Liquidity
Country Finland
Industry Pharmaceuticals
Size Large
Website orionpharma.com
Index
OMX 25
Orion stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
37 32 35 48
Growth
66 76 39 11
Safety
Safety
88 87 76 83
Sentiment
36 77 72 56
360° View
360° View
61 84 65 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
52 45 55 7
Opinions Change
50 77 50 50
Pro Holdings
n/a 100 70 94
Market Pulse
16 32 63 61
Sentiment
36 77 72 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
37 32 35 48
Growth
66 76 39 11
Safety Safety
88 87 76 83
Combined
74 84 46 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
40 15 26 42
Price vs. Earnings (P/E)
27 27 27 39
Price vs. Book (P/B)
16 8 8 22
Dividend Yield
74 85 94 84
Value
37 32 35 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
76 55 63 34
Profit Growth
61 83 8 17
Capital Growth
30 57 76 21
Stock Returns
72 84 28 44
Growth
66 76 39 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
70 70 64 67
Refinancing
70 35 41 46
Liquidity
90 85 90 94
Safety Safety
88 87 76 83

Similar Stocks

Discover high‑ranked alternatives to Orion and broaden your portfolio horizons.

Fresenius

GER:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Strabag

VIE:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Faes Farma

MCE:FAE
Country: Spain
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Yara International

OSL:YAR
Country: Norway
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews